Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$63.83 - $80.0 $240,192 - $301,040
-3,763 Closed
0 $0
Q1 2022

Apr 25, 2022

SELL
$76.85 - $89.45 $5,072 - $5,903
-66 Reduced 1.72%
3,763 $292,000
Q4 2021

Feb 11, 2022

BUY
$74.57 - $87.19 $17,374 - $20,315
233 Added 6.48%
3,829 $329,000
Q3 2021

Nov 05, 2021

SELL
$73.77 - $83.61 $96,048 - $108,860
-1,302 Reduced 26.58%
3,596 $289,000
Q2 2021

Aug 10, 2021

BUY
$80.5 - $88.01 $4,508 - $4,928
56 Added 1.16%
4,898 $394,000
Q1 2021

May 10, 2021

BUY
$76.38 - $86.03 $133,206 - $150,036
1,744 Added 56.29%
4,842 $408,000
Q4 2020

Jan 19, 2021

BUY
$75.39 - $82.36 $24,954 - $27,261
331 Added 11.96%
3,098 $249,000
Q2 2020

Aug 03, 2020

SELL
$78.66 - $94.14 $488,006 - $584,044
-6,204 Reduced 69.16%
2,767 $238,000
Q1 2020

Apr 10, 2020

BUY
$71.57 - $93.3 $48,953 - $63,817
684 Added 8.25%
8,971 $728,000
Q4 2019

Jan 21, 2020

BUY
$76.7 - $88.45 $7,516 - $8,668
98 Added 1.2%
8,287 $693,000
Q3 2019

Oct 16, 2019

BUY
$81.4 - $89.78 $569 - $628
7 Added 0.09%
8,189 $716,000
Q2 2019

Aug 09, 2019

BUY
$73.44 - $82.41 $4,112 - $4,614
56 Added 0.69%
8,182 $670,000
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $140,308 - $176,930
2,176 Added 36.57%
8,126 $661,000
Q4 2018

Feb 08, 2019

SELL
$61.45 - $77.8 $42,707 - $54,071
-695 Reduced 10.46%
5,950 $392,000
Q3 2018

Nov 01, 2018

BUY
$70.71 - $77.75 $10,252 - $11,273
145 Added 2.23%
6,645 $512,000
Q2 2018

Aug 08, 2018

BUY
$63.43 - $75.41 $5,518 - $6,560
87 Added 1.36%
6,500 $480,000
Q1 2018

May 04, 2018

SELL
$62.56 - $72.26 $16,891 - $19,510
-270 Reduced 4.04%
6,413 $417,000
Q4 2017

Feb 09, 2018

BUY
$61.45 - $66.05 $36,870 - $39,630
600 Added 9.86%
6,683 $432,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,083
6,083 $368,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.